← All stories
Deals
Biogen Completes Acquisition of RayThera Inc.
Lead program now in Phase 1 development CAMBRIDGE, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on disc…
Covered by 1 outlet
All coverage · 1 article